GLG Partners’s Zimmer Biomet ZBH Stock Holding History

GLG Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,300	Closed	-$261K	–	529
2017 Q3	$261K	Buy	+2,300	New	+$265K	0.01%	296

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GLG Partners's ZBH Position: Q4 2017 in Review

GLG Partners sold out of Zimmer Biomet (ZBH) in Q4 2017, closing a stake of 2,300 shares — an estimated $261K sold.

GLG Partners first reported a position in ZBH in Q3 2017 and held it in 1 quarter. The position peaked at $261K in Q3 2017. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

GLG Partners reported no remaining Zimmer Biomet position as of Q4 2017 after selling out during the quarter.
GLG Partners sold 2,300 Zimmer Biomet shares in Q4 2017, an estimated $261K.
GLG Partners first reported a position in Zimmer Biomet in Q3 2017 and held it in 1 quarter.
GLG Partners's Zimmer Biomet position peaked at $261K in Q3 2017.
870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.